ACB (Aurora Cannabis Inc. Common Shares) Stock Analysis - AI Report

Aurora Cannabis Inc. Common Shares (ACB) is a publicly traded Healthcare sector company. As of May 21, 2026, ACB trades at $3.48 with a market cap of $193.94M and a P/E ratio of 0.00. ACB moved +5.30% today. Year to date, ACB is -18.93%; over the trailing twelve months it is -35.02%. Its 52-week range spans $3.07 to $6.91. Rallies surfaces ACB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on ACB?

Rallies AI research for ACB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

ACB Key Metrics

Key financial metrics for ACB
MetricValue
Price$3.48
Market Cap$193.94M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.16%
52-Week High$6.91
52-Week Low$3.07
Volume2.16K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ACB News

ACB Analyst Consensus

ACB analyst coverage data. Average price target: $0.00.

Common questions about ACB

What is the AI research view on ACB?
Rallies AI research for ACB combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for ACB?
Rallies AI research for ACB combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is ACB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ACB. It does not provide personalized investment advice.
ACB

ACB